首页> 外国专利> BLOOD BASED IMMUNOPROBE ASSAY USING BIOMARKER POLY-ADP RIBOSYLATION OF CELLULAR PROTEIN FOR EARLY DETECTION OF HUMAN CANCER

BLOOD BASED IMMUNOPROBE ASSAY USING BIOMARKER POLY-ADP RIBOSYLATION OF CELLULAR PROTEIN FOR EARLY DETECTION OF HUMAN CANCER

机译:基于蛋白质的生物标记物多聚ADP核糖基化的基于血的免疫探针测定可用于人类癌症的早期检测

摘要

This invention relates to a blood based immunoprobe assay using biomarker poly-ADP ribosylation of cellular protein for early detection of human cancer comprising, developing antibody against ADP ribose polymers, subsequently raising polyclonal antibody in a rabbit against the natural heterogeneous mixture of ADP-ribose polymers isolated from mouse spleen cells, developing and standardizing and ELISA based immunoprobe assay using the PAb, alkaline-phosphatase (ALP) or horse radish peroxidase (HRP) conjugated second Ab, and 5-Bromo-4-Chloro-3"-Indolyl Phosphate p-Toluidine (BCIP) + Nitro-Blue Tetrazolium Chloride (NBT) based color developer.
机译:本发明涉及一种基于血液的免疫探针测定法,该方法利用细胞蛋白质的生物标志物多ADP核糖基化来早期检测人类癌症,包括开发抗ADP核糖聚合物的抗体,然后在兔体内产生抗ADP核糖聚合物天然异质混合物的多克隆抗体。从小鼠脾细胞中分离,使用PAb,碱性磷酸酶(ALP)或辣根过氧化物酶(HRP)结合的第二抗体和5-Bromo-4-Chloro-3“-吲哚磷酸酯p进行发育,标准化和基于ELISA的免疫探针测定-基于甲苯胺(BCIP)+硝基蓝四氯化氮(NBT)的彩色显影剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号